Cross-resistance to cefoxitin (FOX), chloramphenicol (CMP), and quinolones (nalidixic acid [NAL]) related to a putative efflux system overexpression has recently been reported for Klebsiella pneumoniae. The potential impact of this multidrug resistance (MDR) on the virulence of K. pneumoniae was evaluated in the Caenorhabditis elegans model. For 2 of the 3 MDR clinical isolates studied, a significant increase in acrB transcription was found in comparison with their antibiotic-susceptible revertants. ATCC 138821 and MDR, revertant, and derivative strains with altered porin expression were studied. Strains proved or suspected to overexpress an efflux system were significantly more virulent than the ATCC and revertant strains (time to kill 50% of nematodes [LT 50 ] in days: 3.4 to 3.8 ؎ 0.2 versus 4.1 to 4.4 ؎ 0.3, P < 0.001). Inversely, strains with altered porin expression were significantly less virulent, independently of the expression level of efflux system (LT 50 ؍ 5.4 to 5.6 ؎ 0.2, P < 0.001). Altered porin expression did not change MICs of CMP and NAL but did those of FOX (4 to 16؋ MIC) and ertapenem (16 to 64؋ MIC). The strains with a normally or an overexpressed efflux system that received the -lactamase CTX-M-15 became more widely resistant without modification of their virulence potential, suggesting that balance between resistance and virulence is dependent on the type of resistance mechanisms. In conclusion, this study shows that the expression of both efflux systems and porins is a key factor not only for antibiotic resistance but also virulence potential in K. pneumoniae.Klebsiella pneumoniae, which was recognized over 100 years ago as a cause of community-acquired pneumonia and 20 years ago as a cause of community-acquired pyogenic liver abscesses, is also a common cause of nosocomial infections that range from mild urinary tract infections to severe respiratory tract infections and bacteremia (15,30). Moreover, K. pneumoniae has been found to produce various plasmid-mediated enzymes which confer resistance to most -lactams, particularly the extended-spectrum cephalosporins and more recently carbapenems (2,22,24). Treatment of serious infections caused by extended-spectrum -lactamase (ESBL)-producing K. pneumoniae bacteria is difficult because these organisms are frequently resistant to various other families of antibiotics, including fluoroquinolones (28). Fluoroquinolone resistance in K. pneumoniae arises through specific mutations within the target proteins DNA gyrase and topoisomerase IV and also through a lower uptake of quinolones because of efflux system overexpression (3, 18). Ruzin et al. showed that the resistance to quinolones related to overexpression of the AcrAB efflux pump of K. pneumoniae was associated to resistance to other antibiotics, including chloramphenicol, erythromycin, tetracycline, and also tigecycline, a recently commercialized molecule (32). As for us, we showed that cross-resistance to cefoxitin, chloramphenicol, and quinolones that we observed in bacteremia K. pn...